Suzuken Co., Ltd. (TYO:9987)

Market Cap	344.37B
Revenue (ttm)	2.41T
Net Income (ttm)	34.19B
Shares Out	66.49M
EPS (ttm)	442.96
PE Ratio	11.69
Forward PE	13.71
Dividend	100.00 (1.93%)
Ex-Dividend Date	Mar 28, 2025

Volume	223,700
Average Volume	207,485
Open	5,167.00
Previous Close	5,178.00
Day's Range	5,151.00 - 5,256.00
52-Week Range	4,406.00 - 5,549.00
Beta	0.17
RSI	65.12
Earnings Date	May 13, 2025

About Suzuken

Suzuken Co., Ltd., together with its subsidiaries, primarily engages in the distribution of pharmaceuticals in Japan and internationally. The company operates in four segments: Pharmaceutical Distribution, Pharmaceutical Manufacturing, Pharmacy, and Healthcare-Related Services. The Pharmaceutical Distribution Business segment is involved in the purchase and sale of ethical drugs, pharmaceuticals, diagnostic reagents, and medical equipment and supplies to medical institutions and insurance pharmacies. The Pharmaceutical Manufacturing Business se...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1932
• Employees: 13,086
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 9987

Financial Performance

In 2023, Suzuken's revenue was 2.39 trillion, an increase of 3.10% compared to the previous year's 2.31 trillion. Earnings were 29.02 billion, an increase of 42.62%.